How to CREATE Generic Pharma Competition

How to CREATE Generic Pharma Competition

By harnessing the business incentives of generic drug firms to limit the anticompetitive power of branded pharma­ceutical patent holders, the CREATES Act represents a straight-forward solution to a market failure created by exploitation of legal loopholes in drug industry regulation. It is a remedy that should be strongly supported by the White House and enacted by the new Congress.

No Dodgers, No Merger

No Dodgers, No Merger

The anticompetitive effects of vertical integration by cable systems have now reached crisis proportions with the ongoing refusal — already more than five months old and with no end in sight — of Time Warner to license Los Angeles Dodgers baseball games for cable or satellite distribution, or local broadcast, on any network other than its own SportsNet LA programming channel.

Competition Advocacy Matters—Here’s Why and How

Competition Advocacy Matters—Here’s Why and How

There’s a famous old political adage — “where you stand is where sit” (also known as Miles’ Law) — meaning basically that government policy positions are dictated more by agency imperative and institutional memory than objective consideration of the public interest. A related concept is “regulatory capture,” where administrative agencies over time become defenders of the status quo and pursue objectives more for regulated firms […]